FORWARD Act of 2022

Hozzl · 2022-12-30T04:04:47Z

Explore the details of Senate Bill 3498 FORWARD Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/30/2022, 4:04 AM

Congressional Summary of S 3498

Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2022 or the FORWARD Act of 2022

This bill establishes programs to support research on endemic fungal diseases and the development of antifungal drugs, with a particular focus on Valley Fever. Endemic fungal diseases are fungal infections that tend to occur in specific geographic areas and affect older adults and other at-risk populations.

Specifically, the bill establishes the Endemic Fungal Disease Working Group to review, coordinate, and make recommendations about the Department of Health and Human Services' efforts to address endemic fungal diseases. The working group is comprised of experts from both relevant federal agencies and the private sector.

In addition, the National Institutes of Health must continue its support for research on endemic fungal diseases.

Furthermore, the Food and Drug Administration must issue guidance for entities seeking approval for therapies, diagnostics, and vaccines to prevent and treat Valley Fever. Additionally, the bill provides for the use of priority reviews and other fast-track procedures to incentivize and expedite development and approval of these medical products.

The bill also requires the Biomedical Advanced Research and Development Authority to implement the Combating Antimicrobial Resistance Biopharmaceutical Accelerator Program to reduce and prevent antimicrobial resistance.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3498

Bill S 3498 is currently in the status of Bill Introduced since January 13, 2022. Bill S 3498 was introduced during Congress 117 and was introduced to the Senate on January 13, 2022. Bill S 3498's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 13, 2022

Bipartisan Support of Bill S 3498

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3498

Primary Policy Focus

Health

Potential Impact Areas

- Advisory bodies

- Cardiovascular and respiratory health

- Congressional oversight

- Department of Health and Human Services

- Drug safety, medical device, and laboratory regulation

- Drug therapy

- Emergency medical services and trauma care

- Executive agency funding and structure

- Government information and archives

- Health programs administration and funding

- Health promotion and preventive care

- Immunology and vaccination

- Infectious and parasitic diseases

- Licensing and registrations

- Medical research

- Medical tests and diagnostic methods

- Research administration and funding

Alternate Title(s) of Bill S 3498

FORWARD Act of 2022

Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2022

A bill to support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes.